Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Patient-Controlled Analgesic Pumps Market, by Type
1.4.2 North America Patient-Controlled Analgesic Pumps Market, by Application
1.4.3 North America Patient-Controlled Analgesic Pumps Market, by End Use
1.4.4 North America Patient-Controlled Analgesic Pumps Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements,
3.2.2 Geographical Expansions
3.2.3 Approvals & Trials
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. North America Patient-Controlled Analgesic Pumps Market by Type
4.1 North America Electronic Market by Country
4.2 North America Mechanical Market by Country
Chapter 5. North America Patient-Controlled Analgesic Pumps Market by Application
5.1 North America Oncology Market by Country
5.2 North America Diabetes Market by Country
5.3 North America Hematology Market by Country
5.4 North America Gastroenterology Market by Country
5.5 North America Other Application Market by Country
Chapter 6. North America Patient-Controlled Analgesic Pumps Market by End-use
6.1 North America Hospitals Market by Country
6.2 North America Specialty Clinics Market by Country
6.3 North America Ambulatory Surgical Centers Market by Country
6.4 North America Home Care Settings Market by Country
Chapter 7. North America Patient-Controlled Analgesic Pumps Market by Country
7.1 US Patient-Controlled Analgesic Pumps Market
7.1.1 US Patient-Controlled Analgesic Pumps Market by Type
7.1.2 US Patient-Controlled Analgesic Pumps Market by Application
7.1.3 US Patient-Controlled Analgesic Pumps Market by End-use
7.2 Canada Patient-Controlled Analgesic Pumps Market
7.2.1 Canada Patient-Controlled Analgesic Pumps Market by Type
7.2.2 Canada Patient-Controlled Analgesic Pumps Market by Application
7.2.3 Canada Patient-Controlled Analgesic Pumps Market by End-use
7.3 Mexico Patient-Controlled Analgesic Pumps Market
7.3.1 Mexico Patient-Controlled Analgesic Pumps Market by Type
7.3.2 Mexico Patient-Controlled Analgesic Pumps Market by Application
7.3.3 Mexico Patient-Controlled Analgesic Pumps Market by End-use
7.4 Rest of North America Patient-Controlled Analgesic Pumps Market
7.4.1 Rest of North America Patient-Controlled Analgesic Pumps Market by Type
7.4.2 Rest of North America Patient-Controlled Analgesic Pumps Market by Application
7.4.3 Rest of North America Patient-Controlled Analgesic Pumps Market by End-use
Chapter 8. Company Profiles
8.1 Smiths Group PLC
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Approvals & Trials:
8.2 Fresenius SE & Co. KGaA
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.3 B. Braun Melsungen AG
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.4 Baxter International, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.1 Recent strategies and developments:
8.4.1.1 Approvals & Trials:
8.4.1.2 Acquisition and Mergers:
8.5 Becton, Dickinson and Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals & Trials:
8.5.5.2 Acquisition and Mergers:
8.6 Terumo Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.4.2 Approvals & Trials:
8.7 Abbott Laboratories
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Avante Health Solutions
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 ICU Medical, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Acquisition and Mergers:
8.9.2.3 Geographical Expansions:
8.10. Ace Medical Co., Ltd.
8.10.1 Company Overview
Unique Offerings 